Unichem Laboratories Limited, a pharmaceutical company, manufactures and sells pharmaceutical products in India, the United States, and internationally. The company offers formulation products that address various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infective, and pain management. It also offers active pharmaceutical ingredients, as well as contract manufacturing services. In addition, the company manufactures allopathic medicines, bulk drugs, and chemicals. It serves patients, distributors, health care professionals, and government institutions. The company was founded in 1944 and is based in Mumbai, India. Unichem Laboratories Limited is a subsidiary of Ipca Laboratories Limited.
| Current Price | ₹365.20 |
|---|---|
| Market Cap | ₹2,571 Cr |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Medicinal Chemicals and Botanical Products |
| P/E Ratio | 18.8 |
| Return on Equity | 5.63% |
| 52-Week Range | ₹278.20 – ₹666.60 |
| Beta (1Y) | 0.45 |
| Dividend Yield | 0.00% |
1. Pharmaceuticals-100%
Unichem Laboratories Ltd. is trading at ₹365.20, with a market capitalisation of ₹2,571 Cr.
Unichem Laboratories Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Medicinal Chemicals and Botanical Products).
Unichem Laboratories Ltd. has a P/E of 18.8 and a return on equity of 5.63%.